ArticleObesity facts2026

The GLP-1 Agonist Exenatide Is Associated with Improved Adherence to Health Behavior and Lifestyle Treatment in Adolescents with Obesity: A Randomized Controlled Trial.

Rasmus Stenlid et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.